Home
Random
Nearby
Log in
Settings
Donate
About Wikidata
Disclaimers
Search
(Q28258769)
Watch
English
Management of HCC
scientific article
In more languages
edit
Statements
instance of
scholarly article
0 references
title
Management of HCC
(English)
0 references
main subject
hepatocellular carcinoma
1 reference
based on heuristic
inferred from title
author
María Reig
object named as
María Reig
series ordinal
4
0 references
Alejandro Forner
object named as
Alejandro Forner
series ordinal
3
0 references
Jordi Bruix
object named as
Jordi Bruix
series ordinal
5
0 references
Carlos Rodriguez-Lope
series ordinal
1
object named as
Carlos Rodríguez de Lope
0 references
Silvia Tremosini
series ordinal
2
object named as
Silvia Tremosini
0 references
language of work or name
English
0 references
publication date
2012
0 references
published in
Journal of Hepatology
0 references
volume
56 Suppl 1
0 references
page(s)
S75-87
0 references
cites work
Estimates of worldwide burden of cancer in 2008: GLOBOCAN 2008
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0168-8278%2812%2960009-9
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Primary liver cancer: worldwide incidence and trends
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0168-8278%2812%2960009-9
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Natural history of hepatitis-related hepatocellular carcinoma.
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0168-8278%2812%2960009-9
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Natural history and prognostic factors for chronic hepatitis type B
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0168-8278%2812%2960009-9
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Hepatitis B e antigen and the risk of hepatocellular carcinoma
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0168-8278%2812%2960009-9
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Nomograms for risk of hepatocellular carcinoma in patients with chronic hepatitis B virus infection
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0168-8278%2812%2960009-9
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Morbidity and mortality in compensated cirrhosis type C: a retrospective follow-up study of 384 patients
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0168-8278%2812%2960009-9
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Hepatitis C virus related cirrhosis: time to occurrence of hepatocellular carcinoma and death.
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0168-8278%2812%2960009-9
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Incidence of hepatocellular carcinoma and associated risk factors in hepatitis C-related advanced liver disease
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0168-8278%2812%2960009-9
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Management of hepatocellular carcinoma: An update
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0168-8278%2812%2960009-9
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Alcoholic liver disease.
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0168-8278%2812%2960009-9
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Prospective analysis of risk factors for hepatocellular carcinoma in patients with liver cirrhosis
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0168-8278%2812%2960009-9
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Risk factors for hepatocellular carcinoma: synergism of alcohol with viral hepatitis and diabetes mellitus
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0168-8278%2812%2960009-9
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Overweight, Obesity, and Mortality from Cancer in a Prospectively Studied Cohort of U.S. Adults
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0168-8278%2812%2960009-9
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Diabetes increases the risk of chronic liver disease and hepatocellular carcinoma
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0168-8278%2812%2960009-9
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Insights into the pathogenesis and treatment of cancer from inborn errors of metabolism
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0168-8278%2812%2960009-9
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Gender disparity in liver cancer due to sex differences in MyD88-dependent IL-6 production
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0168-8278%2812%2960009-9
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Principles of cancer screening: lessons from history and study design issues
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0168-8278%2812%2960009-9
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Meta-analysis: surveillance with ultrasound for early-stage hepatocellular carcinoma in patients with cirrhosis.
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0168-8278%2812%2960009-9
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Computed Tomography — An Increasing Source of Radiation Exposure
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0168-8278%2812%2960009-9
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Serological surveillance for hepatocellular carcinoma: time to quit
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0168-8278%2812%2960009-9
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Serum alpha-fetoprotein levels in patients with advanced hepatitis C: results from the HALT-C Trial.
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0168-8278%2812%2960009-9
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Correlation between clinical indication for treatment and liver histology in HBeAg-negative chronic hepatitis B: a novel role of alpha-fetoprotein.
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0168-8278%2812%2960009-9
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Alpha-fetoprotein-producing clear cell carcinoma of the extrahepatic bile ducts
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0168-8278%2812%2960009-9
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Clinicopathologic features and prognostic factors in alpha-fetoprotein-producing gastric cancers: analysis of 104 cases.
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0168-8278%2812%2960009-9
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Measurement of serum levels of des-gamma-carboxy prothrombin in patients with hepatocellular carcinoma by a revised enzyme immunoassay kit with increased sensitivity
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0168-8278%2812%2960009-9
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Des-gamma carboxyprothrombin can differentiate hepatocellular carcinoma from nonmalignant chronic liver disease in american patients
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0168-8278%2812%2960009-9
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Glypican-3: a novel serum and histochemical marker for hepatocellular carcinoma
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0168-8278%2812%2960009-9
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Alpha-fetoprotein, des-gamma carboxyprothrombin, and lectin-bound alpha-fetoprotein in early hepatocellular carcinoma
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0168-8278%2812%2960009-9
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Randomized controlled trial of screening for hepatocellular carcinoma
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0168-8278%2812%2960009-9
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Surveillance programme of cirrhotic patients for early diagnosis and treatment of hepatocellular carcinoma: a cost effectiveness analysis.
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0168-8278%2812%2960009-9
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Increased survival of cirrhotic patients with a hepatocellular carcinoma detected during surveillance
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0168-8278%2812%2960009-9
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Semiannual surveillance is superior to annual surveillance for the detection of early hepatocellular carcinoma and patient survival.
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0168-8278%2812%2960009-9
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Ultrasonographic surveillance of hepatocellular carcinoma in cirrhosis: A randomized trial comparing 3- and 6-month periodicities
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0168-8278%2812%2960009-9
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Early hepatocellular carcinoma and dysplastic nodules
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0168-8278%2812%2960009-9
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Pathologic diagnosis of early hepatocellular carcinoma: a report of the international consensus group for hepatocellular neoplasia
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0168-8278%2812%2960009-9
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
The application of markers (HSP70 GPC3 and GS) in liver biopsies is useful for detection of hepatocellular carcinoma
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0168-8278%2812%2960009-9
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Diagnosis of hepatic nodules 20 mm or smaller in cirrhosis: Prospective validation of the noninvasive diagnostic criteria for hepatocellular carcinoma.
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0168-8278%2812%2960009-9
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Intrahepatic peripheral cholangiocarcinoma in cirrhosis patients may display a vascular pattern similar to hepatocellular carcinoma on contrast-enhanced ultrasound
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0168-8278%2812%2960009-9
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
A comparison of trends in the incidence of hepatocellular carcinoma and intrahepatic cholangiocarcinoma in the United States
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0168-8278%2812%2960009-9
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Changing international trends in mortality rates for liver, biliary and pancreatic tumours
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0168-8278%2812%2960009-9
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Current strategy for staging and treatment: the BCLC update and future prospects.
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0168-8278%2812%2960009-9
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Prospective validation of the Barcelona Clinic Liver Cancer staging system
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0168-8278%2812%2960009-9
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Prognostic factors for survival in patients with early-intermediate hepatocellular carcinoma undergoing non-surgical therapy: comparison of Okuda, CLIP, and BCLC staging systems in a single Italian centre.
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0168-8278%2812%2960009-9
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Prognosis of hepatocellular carcinoma: comparison of 7 staging systems in an American cohort
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0168-8278%2812%2960009-9
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Clinical management of hepatocellular carcinoma. Conclusions of the Barcelona-2000 EASL conference. European Association for the Study of the Liver
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0168-8278%2812%2960009-9
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Arterial embolisation or chemoembolisation versus symptomatic treatment in patients with unresectable hepatocellular carcinoma: a randomised controlled trial
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0168-8278%2812%2960009-9
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Sorafenib in advanced hepatocellular carcinoma
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0168-8278%2812%2960009-9
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Results of surgical and nonsurgical treatment for small-sized hepatocellular carcinomas: a retrospective and nationwide survey in Japan. The Liver Cancer Study Group of Japan
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0168-8278%2812%2960009-9
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Percutaneous radiofrequency ablation for early-stage hepatocellular carcinoma as a first-line treatment: long-term results and prognostic factors in a large single-institution series
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0168-8278%2812%2960009-9
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Randomised controlled trial comparing percutaneous radiofrequency thermal ablation, percutaneous ethanol injection, and percutaneous acetic acid injection to treat hepatocellular carcinoma of 3 cm or less
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0168-8278%2812%2960009-9
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Sustained complete response and complications rates after radiofrequency ablation of very early hepatocellular carcinoma in cirrhosis: Is resection still the treatment of choice?
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0168-8278%2812%2960009-9
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Treatment of hepatocellular carcinoma by percutaneous tumor ablation methods: Ethanol injection therapy and radiofrequency ablation
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0168-8278%2812%2960009-9
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Initial response to percutaneous ablation predicts survival in patients with hepatocellular carcinoma.
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0168-8278%2812%2960009-9
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
A randomized controlled trial of radiofrequency ablation with ethanol injection for small hepatocellular carcinoma.
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0168-8278%2812%2960009-9
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Percutaneous radiofrequency ablation for hepatocellular carcinoma. An analysis of 1000 cases
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0168-8278%2812%2960009-9
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Classification and prediction of survival in hepatocellular carcinoma by gene expression profiling.
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0168-8278%2812%2960009-9
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Transcriptome classification of HCC is related to gene alterations and to new therapeutic targets
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0168-8278%2812%2960009-9
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Integrative transcriptome analysis reveals common molecular subclasses of human hepatocellular carcinoma
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0168-8278%2812%2960009-9
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Design and endpoints of clinical trials in hepatocellular carcinoma.
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0168-8278%2812%2960009-9
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Randomized controlled trial of transarterial lipiodol chemoembolization for unresectable hepatocellular carcinoma
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0168-8278%2812%2960009-9
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Transcatheter chemoembolization in the treatment of HCC in patients not eligible for curative treatments: midterm results of doxorubicin-loaded DC bead
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0168-8278%2812%2960009-9
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Overall survival after transarterial lipiodol infusion chemotherapy with or without embolization for unresectable hepatocellular carcinoma: propensity score analysis
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0168-8278%2812%2960009-9
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
A meta-analysis of survival rates of untreated patients in randomized clinical trials of hepatocellular carcinoma
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0168-8278%2812%2960009-9
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
The surgical approach to HCC: our progress and results in Japan
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0168-8278%2812%2960009-9
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Resection and liver transplantation for hepatocellular carcinoma.
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0168-8278%2812%2960009-9
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Surgical strategies for hepatocellular carcinoma with special reference to anatomical hepatic resection and intraoperative contrast-enhanced ultrasonography
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0168-8278%2812%2960009-9
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Comparison of the outcomes between an anatomical subsegmentectomy and a non-anatomical minor hepatectomy for single hepatocellular carcinomas based on a Japanese nationwide survey
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0168-8278%2812%2960009-9
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Anatomic resection independently improves long-term survival in patients with T1-T2 hepatocellular carcinoma
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0168-8278%2812%2960009-9
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Risk factors contributing to early and late phase intrahepatic recurrence of hepatocellular carcinoma after hepatectomy.
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0168-8278%2812%2960009-9
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Prognostic impact of anatomic resection for hepatocellular carcinoma
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0168-8278%2812%2960009-9
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Partial hepatectomy with wide versus narrow resection margin for solitary hepatocellular carcinoma: a prospective randomized trial.
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0168-8278%2812%2960009-9
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Different risk factors and prognosis for early and late intrahepatic recurrence after resection of hepatocellular carcinoma
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0168-8278%2812%2960009-9
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
A system of classifying microvascular invasion to predict outcome after resection in patients with hepatocellular carcinoma
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0168-8278%2812%2960009-9
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Laparoscopic versus open liver resection for hepatocellular carcinoma in patients with histologically proven cirrhosis: short- and middle-term results
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0168-8278%2812%2960009-9
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Meta-analysis of laparoscopic versus open resection for hepatocellular carcinoma
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0168-8278%2812%2960009-9
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Natural history and prognostic indicators of survival in cirrhosis: a systematic review of 118 studies
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0168-8278%2812%2960009-9
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Intention-to-treat analysis of surgical treatment for early hepatocellular carcinoma: resection versus transplantation
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0168-8278%2812%2960009-9
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Neither multiple tumors nor portal hypertension are surgical contraindications for hepatocellular carcinoma
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0168-8278%2812%2960009-9
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Clinical practice guidelines for hepatocellular carcinoma: the first evidence based guidelines from Japan
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0168-8278%2812%2960009-9
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Prediction of microvascular invasion before curative resection of hepatocellular carcinoma.
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0168-8278%2812%2960009-9
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
The predictors of microvascular invasion in candidates for liver transplantation with hepatocellular carcinoma-with special reference to the serum levels of des-gamma-carboxy prothrombin
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0168-8278%2812%2960009-9
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Microvascular invasion in hepatocellular carcinoma: is it predictable with pretransplant MRI?
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0168-8278%2812%2960009-9
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Predictors of microvascular invasion before hepatectomy for hepatocellular carcinoma.
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0168-8278%2812%2960009-9
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Predictor for histological microvascular invasion of hepatocellular carcinoma: a lesson from 229 consecutive cases of curative liver resection
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0168-8278%2812%2960009-9
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Predictive factors of microvascular invasion in patients with hepatocellular carcinoma larger than 5 cm
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0168-8278%2812%2960009-9
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Predictors of microvascular invasion in patients with hepatocellular carcinoma who are candidates for orthotopic liver transplantation
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0168-8278%2812%2960009-9
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Overexpression of osteopontin independently correlates with vascular invasion and poor prognosis in patients with hepatocellular carcinoma
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0168-8278%2812%2960009-9
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Alpha-fetoprotein and tumour size are associated with microvascular invasion in explanted livers of patients undergoing transplantation with hepatocellular carcinoma
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0168-8278%2812%2960009-9
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Gene-expression signature of vascular invasion in hepatocellular carcinoma.
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0168-8278%2812%2960009-9
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
A randomized trial comparing radiofrequency ablation and surgical resection for HCC conforming to the Milan criteria
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0168-8278%2812%2960009-9
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
A prospective randomized trial comparing percutaneous local ablative therapy and partial hepatectomy for small hepatocellular carcinoma
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0168-8278%2812%2960009-9
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Transarterial chemoembolization in very early and early-stage hepatocellular carcinoma patients excluded from curative treatment: a prospective cohort study.
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0168-8278%2812%2960009-9
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Hepatic resection versus radiofrequency ablation for very early stage hepatocellular carcinoma: a Markov model analysis.
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0168-8278%2812%2960009-9
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
High pathological risk of recurrence after surgical resection for hepatocellular carcinoma: an indication for salvage liver transplantation.
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0168-8278%2812%2960009-9
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Benefit of initial resection of hepatocellular carcinoma followed by transplantation in case of recurrence: an intention-to-treat analysis.
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0168-8278%2812%2960009-9
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Gene expression in fixed tissues and outcome in hepatocellular carcinoma.
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0168-8278%2812%2960009-9
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
What should physicians look for in evaluating prognostic gene-expression signatures?
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0168-8278%2812%2960009-9
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
A prospective, randomized, controlled trial of preoperative transarterial chemoembolization for resectable large hepatocellular carcinoma
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0168-8278%2812%2960009-9
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Adjuvant intra-arterial iodine-131-labelled lipiodol for resectable hepatocellular carcinoma: a prospective randomised trial
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0168-8278%2812%2960009-9
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Adoptive immunotherapy to lower postsurgical recurrence rates of hepatocellular carcinoma: a randomised trial
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0168-8278%2812%2960009-9
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Prevention of second primary tumors by an acyclic retinoid, polyprenoic acid, in patients with hepatocellular carcinoma. Hepatoma Prevention Study Group
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0168-8278%2812%2960009-9
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Systematic review and meta-analysis of interferon after curative treatment of hepatocellular carcinoma in patients with viral hepatitis.
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0168-8278%2812%2960009-9
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Meta-analysis: interferon-alpha prevents the recurrence after curative treatment of hepatitis C virus-related hepatocellular carcinoma
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0168-8278%2812%2960009-9
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Adjuvant interferon therapy after curative therapy for hepatocellular carcinoma (HCC): a meta-regression approach
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0168-8278%2812%2960009-9
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Hepatic resection versus transplantation for hepatocellular carcinoma
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0168-8278%2812%2960009-9
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Role of liver transplantation in cancer therapy
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0168-8278%2812%2960009-9
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Liver transplantation for the treatment of small hepatocellular carcinomas in patients with cirrhosis
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0168-8278%2812%2960009-9
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Liver transplantation for small hepatocellular carcinoma: The tumor-node-metastasis classification does not have prognostic power
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0168-8278%2812%2960009-9
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Vascular invasion and histopathologic grading determine outcome after liver transplantation for hepatocellular carcinoma in cirrhosis
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0168-8278%2812%2960009-9
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Liver transplantation for hepatocellular carcinoma: expansion of the tumor size limits does not adversely impact survival
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0168-8278%2812%2960009-9
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Liver organ allocation for hepatocellular carcinoma: are we sure?
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0168-8278%2812%2960009-9
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Liver transplantation for the treatment of moderately or well-differentiated hepatocellular carcinoma
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0168-8278%2812%2960009-9
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Impact of UCSF criteria according to pre- and post-OLT tumor features: analysis of 479 patients listed for HCC with a short waiting time.
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0168-8278%2812%2960009-9
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Liver transplantation criteria for hepatocellular carcinoma should be expanded: a 22-year experience with 467 patients at UCLA
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0168-8278%2812%2960009-9
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Expanded criteria for liver transplantation in patients with hepatocellular carcinoma: a report from the International Registry of Hepatic Tumors in Liver Transplantation
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0168-8278%2812%2960009-9
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Liver transplantation in patients with hepatocellular carcinoma across Milan criteria
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0168-8278%2812%2960009-9
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Total tumor volume predicts risk of recurrence following liver transplantation in patients with hepatocellular carcinoma
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0168-8278%2812%2960009-9
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Predicting survival after liver transplantation in patients with hepatocellular carcinoma beyond the Milan criteria: a retrospective, exploratory analysis
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0168-8278%2812%2960009-9
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Long-term results with multimodal adjuvant therapy and liver transplantation for the treatment of hepatocellular carcinomas larger than 5 centimeters
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0168-8278%2812%2960009-9
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Report of a national conference on liver allocation in patients with hepatocellular carcinoma in the United States
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0168-8278%2812%2960009-9
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
A follow-up analysis of the pattern and predictors of dropout from the waiting list for liver transplantation in patients with hepatocellular carcinoma: implications for the current organ allocation policy
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0168-8278%2812%2960009-9
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Drop-out rates of patients with hepatocellular cancer listed for liver transplantation: outcome with chemoembolization
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0168-8278%2812%2960009-9
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Waiting list removal rates among patients with chronic and malignant liver diseases.
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0168-8278%2812%2960009-9
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Hepatocellular carcinoma patients are advantaged in the current liver transplant allocation system
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0168-8278%2812%2960009-9
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Outcomes in hepatitis C virus-infected recipients of living donor vs. deceased donor liver transplantation
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0168-8278%2812%2960009-9
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Applicability of adult-to-adult living donor liver transplantation
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0168-8278%2812%2960009-9
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Donor morbidity after living donation for liver transplantation
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0168-8278%2812%2960009-9
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Living-donor liver transplantation for hepatocellular carcinoma
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0168-8278%2812%2960009-9
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Living donor liver transplantation for adult patients with hepatocellular carcinoma: experience in Japan
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0168-8278%2812%2960009-9
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Adult living donor liver transplantation for patients with hepatocellular carcinoma: extending UNOS priority criteria
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0168-8278%2812%2960009-9
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Expansion of selection criteria for patients with hepatocellular carcinoma in living donor liver transplantation
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0168-8278%2812%2960009-9
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Living donor liver transplantation of the right lobe for hepatocellular carcinoma in cirrhosis in a European center
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0168-8278%2812%2960009-9
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Hepatocellular carcinoma recurrence and death following living and deceased donor liver transplantation
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0168-8278%2812%2960009-9
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Living donor liver transplantation for early hepatocellular carcinoma: A life-expectancy and cost-effectiveness perspective
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0168-8278%2812%2960009-9
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Cost effectiveness of adjuvant therapy for hepatocellular carcinoma during the waiting list for liver transplantation
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0168-8278%2812%2960009-9
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Management of hepatocellular carcinoma on the waiting list before liver transplantation: time for controlled trials?
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0168-8278%2812%2960009-9
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
A model to predict survival in patients with end-stage liver disease
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0168-8278%2812%2960009-9
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
The new liver allocation system: moving toward evidence-based transplantation policy
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0168-8278%2812%2960009-9
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Loco-regional treatment of hepatocellular carcinoma
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0168-8278%2812%2960009-9
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Small hepatocellular carcinoma in cirrhosis: randomized comparison of radio-frequency thermal ablation versus percutaneous ethanol injection
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0168-8278%2812%2960009-9
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Radiofrequency ablation versus ethanol injection for early hepatocellular carcinoma: A randomized controlled trial
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0168-8278%2812%2960009-9
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Small hepatocellular carcinoma: treatment with radio-frequency ablation versus ethanol injection
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0168-8278%2812%2960009-9
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Clinical outcomes of radiofrequency ablation, percutaneous alcohol and acetic acid injection for hepatocelullar carcinoma: a meta-analysis
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0168-8278%2812%2960009-9
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Systematic review of randomized trials for hepatocellular carcinoma treated with percutaneous ablation therapies
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0168-8278%2812%2960009-9
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Radiofrequency thermal ablation vs. percutaneous ethanol injection for small hepatocellular carcinoma in cirrhosis: meta-analysis of randomized controlled trials.
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0168-8278%2812%2960009-9
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Needle track seeding following percutaneous procedures for hepatocellular carcinoma
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0168-8278%2812%2960009-9
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Early-stage hepatocellular carcinoma in patients with cirrhosis: long-term results of percutaneous image-guided radiofrequency ablation.
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0168-8278%2812%2960009-9
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Hepatic arterial embolization in patients with unresectable hepatocellular carcinoma--a randomized controlled trial
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0168-8278%2812%2960009-9
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
A comparison of lipiodol chemoembolization and conservative treatment for unresectable hepatocellular carcinoma
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0168-8278%2812%2960009-9
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Transarterial embolization versus symptomatic treatment in patients with advanced hepatocellular carcinoma: results of a randomized, controlled trial in a single institution.
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0168-8278%2812%2960009-9
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Treatment of unresectable hepatocellular carcinoma with lipiodol chemoembolization: a multicenter randomized trial. Groupe CHC
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0168-8278%2812%2960009-9
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Systematic review of randomized trials for unresectable hepatocellular carcinoma: Chemoembolization improves survival
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0168-8278%2812%2960009-9
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Transarterial chemoembolization for unresectable hepatocellular carcinoma: meta-analysis of randomized controlled trials.
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0168-8278%2812%2960009-9
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Transarterial therapy for hepatocellular carcinoma: which technique is more effective? A systematic review of cohort and randomized studies.
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0168-8278%2812%2960009-9
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Chemoembolization of hepatocellular carcinoma with drug eluting beads: efficacy and doxorubicin pharmacokinetics.
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0168-8278%2812%2960009-9
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Prospective randomized study of doxorubicin-eluting-bead embolization in the treatment of hepatocellular carcinoma: results of the PRECISION V study
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0168-8278%2812%2960009-9
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Hepatic tumors: predisposing factors for complications of transcatheter oily chemoembolization
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0168-8278%2812%2960009-9
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
A prospective study regarding the complications of transcatheter intraarterial lipiodol chemoembolization in patients with hepatocellular carcinoma
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0168-8278%2812%2960009-9
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Evaluation of tumor response after locoregional therapies in hepatocellular carcinoma: are response evaluation criteria in solid tumors reliable?
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0168-8278%2812%2960009-9
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Modified RECIST (mRECIST) assessment for hepatocellular carcinoma
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0168-8278%2812%2960009-9
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Radioembolization for hepatocellular carcinoma using Yttrium-90 microspheres: a comprehensive report of long-term outcomes
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0168-8278%2812%2960009-9
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Radioembolization results in longer time-to-progression and reduced toxicity compared with chemoembolization in patients with hepatocellular carcinoma
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0168-8278%2812%2960009-9
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Safety and efficacy of 90Y radiotherapy for hepatocellular carcinoma with and without portal vein thrombosis
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0168-8278%2812%2960009-9
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Hallmarks of Cancer: The Next Generation
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0168-8278%2812%2960009-9
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Efficacy and safety of sorafenib in patients in the Asia-Pacific region with advanced hepatocellular carcinoma: a phase III randomised, double-blind, placebo-controlled trial
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0168-8278%2812%2960009-9
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Cetuximab for the treatment of colorectal cancer.
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0168-8278%2812%2960009-9
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Paclitaxel-carboplatin alone or with bevacizumab for non-small-cell lung cancer
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0168-8278%2812%2960009-9
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Molecular targeted therapies in hepatocellular carcinoma
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0168-8278%2812%2960009-9
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Targeted therapies for hepatocellular carcinoma.
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0168-8278%2812%2960009-9
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Prolonged Therapy of Advanced Chronic Hepatitis C with Low-Dose Peginterferon
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0168-8278%2812%2960009-9
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Maintenance therapy with peginterferon alfa-2b does not prevent hepatocellular carcinoma in cirrhotic patients with chronic hepatitis C.
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0168-8278%2812%2960009-9
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Identifiers
DOI
10.1016/S0168-8278(12)60009-9
1 reference
stated in
Consolidated OpenCitations Corpus – April 2017
OpenCitations bibliographic resource ID
1975314
OpenCitations bibliographic resource ID
1975314
1 reference
stated in
Consolidated OpenCitations Corpus – April 2017
OpenCitations bibliographic resource ID
1975314
PubMed publication ID
22300468
1 reference
stated in
Consolidated OpenCitations Corpus – April 2017
OpenCitations bibliographic resource ID
1975314
Sitelinks
Wikipedia
(0 entries)
edit
Wikibooks
(0 entries)
edit
Wikinews
(0 entries)
edit
Wikiquote
(0 entries)
edit
Wikisource
(0 entries)
edit
Wikiversity
(0 entries)
edit
Wikivoyage
(0 entries)
edit
Wiktionary
(0 entries)
edit
Multilingual sites
(0 entries)
edit
